Annual report pursuant to Section 13 and 15(d)

Royalty Purchase Agreements - Bioasis (Details)

v3.20.1
Royalty Purchase Agreements - Bioasis (Details)
$ in Thousands
 12 Months Ended
Feb. 25, 2019
USD ($)
agreement
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Licensing and other arrangements      
Payments to acquire milestones and royalties   $ 19,300 $ 15,000
Contingent consideration under royalty purchase agreements   75  
Long-term royalty receivables   34,375 15,000
Impairment of long-term royalty receivable   0 $ 0
Bioasis Technologies Inc | Royalty Purchase Agreement      
Licensing and other arrangements      
Percentage of option to purchase royalty right on future license agreements 1.00%    
Number of future license agreements under optional purchase right | agreement 2    
Obligation upon exercise of options per licensed product, second agreement $ 300    
Obligation upon exercise of options per licensed product, third agreement 400    
Payments to acquire milestones and royalties 300    
Contingent consideration under royalty purchase agreements 100 100  
Potential future cash payments 200    
Long-term royalty receivables $ 400    
Changes in estimated fair value of contingent consideration   0  
Payments of contingent consideration   0  
Impairment of long-term royalty receivable   $ 0